Literature DB >> 11355

Absorption, utilization, and safety of aspartic acid.

L D Stegink.   

Abstract

The dicarboxylic amino acids, asparate and glutamate, occupy unique positions in intermediary metabolism, particularly in the mitochondria, where they play important roles in nitrogen and energy metabolism. Administration of large quantities of glutamate and asparate to the newborn mouse produces a variety of neurotoxic effects, the most marked of which is neuronal necrosis. Neurotoxic effects of glutamate and aspartate in animal species other than the rodent are highly controversial. In the most critical animal species, the infant subhuman primate, at least four research groups have failed to duplicate the original report of glutamate-induced neuronal necrosis. Marked elevations in plasma glutamate or aspartate must occur for development of neuronal necrosis. In the highly sensitive neonatal mouse, plasma glutamate plus plasma aspartate levels must reach 60-80 mumol/dl to produce even minimal neuronal necrosis. In the healthy neonatal primate, loads producing plasma glutamate levels ranging from 50 to 1,600 mumol/dl failed to produce neuronal necrosis in our studies. Thus, it is clear that (1) marked elevations in plasma glutamate and aspartate must occur for neuronal necrosis, and (2) threshold levels required to produce neuronal necrosis vary greatly with species. The available data indicate little danger to the healthy primate and humans from ingestion of the dicarboxylic amino acids under anything resembling a reasonable intake. However, there is no doubt that these amino acids are toxic to the neonatal mouse at high dose levels.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 11355     DOI: 10.1080/15287397609529428

Source DB:  PubMed          Journal:  J Toxicol Environ Health        ISSN: 0098-4108


  3 in total

1.  Drinking behavior and the development of hypothalamic lesions from aspartame ingestion in water-restricted weanling mice.

Authors:  Y Takasaki; S Iwata; K Torii
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

2.  Pharmacokinetics of arginine and aspartic acid administered simultaneously in the rat: II. Tissue distribution.

Authors:  G Campistron; R Guiraud; J Cros; G Prat
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Oct-Dec       Impact factor: 2.441

3.  Pharmacokinetics of arginine and aspartic acid administered simultaneously in the rat--III: Changes in the levels of amino acids in the plasma, liver and brain after simultaneous administration of arginine and aspartic acid.

Authors:  G Campistron; R Guiraud; J Cros; H Pontagnier
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Jul-Sep       Impact factor: 2.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.